• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单侧 cN0 期甲状腺乳头状癌对侧中央区淋巴结转移的危险因素:一项荟萃分析。

Risk factors for contralateral central lymph node metastasis in unilateral cN0 papillary thyroid carcinoma: A meta-analysis.

机构信息

Department of General Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.

Department of Pathology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.

出版信息

Int J Surg. 2018 Nov;59:90-98. doi: 10.1016/j.ijsu.2018.09.004. Epub 2018 Oct 17.

DOI:10.1016/j.ijsu.2018.09.004
PMID:30342280
Abstract

BACKGROUND

Central lymph node metastasis(CLNM) is common in papillary thyroid carcinoma(PTC). LNM is related to local recurrence and adverse prognosis. The extent of prophylactic central lymph node dissection(pCLND) is not well defined. We aim to investigate the prevalence and risk factors for contralateral central lymph node metastasis (CCLNM) in unilateral clinical node-negative (cN0) PTC patients to determine the appropriate extent of pCLND.

METHODS

A systematic literature search was performed using PubMed and Embase databases until May 2018. Published studies that estimated the association between clinicopathologic factors and CCLNM were included.

RESULTS

A total of 6 studies involving 1399 patients were included. The prevalence of CCLNM was 10.9% in all patients. The pooled analysis revealed that male gender (pooled OR = 1.67, 95%CI = 1.11-2.53, p = 0.015), age<45years (pooled OR = 1.97, 95%CI = 1.37-2.85, p < 0.001), lymphovasular invasion (pooled OR = 4.23, 95%CI = 2.25-7.98, p < 0.001), extrathyroid invasion (pooled OR = 1.75, 95%CI = 1.08-2.83, p = 0.023), and ipsilateral CLNM (pooled OR = 12.26, 95%CI = 7.27-20.67, p < 0.001) were significant risk factors for CCLNM. While tumor size>1 cm (pooled OR = 3.39, 95%CI = 0.83-13.88, P = 0.090), capsular invasion (pooled OR = 1.28, 95%CI = 0.79-2.06, p = 0.313), extrathyroid extension (pooled OR = 1.49, 95%CI = 0.86-2.56, p = 0.152), and MACIS≥6 (pooled OR = 1.08, 95%CI = 0.51-2.26, p = 0.844) were not significantly associated with CCLNM.

CONCLUSIONS

Our meta-analysis identified that male gender, age<45years, lymphovasular invasion, extrathyroid invasion and ipsilateral CLNM were significant risk factors for CCLNM. These findings may guide the extent of pCLND in unilateral cN0 PTC patients.

摘要

背景

中央淋巴结转移(CLNM)在甲状腺乳头状癌(PTC)中很常见。LNM 与局部复发和不良预后有关。预防性中央淋巴结清扫术(pCLND)的范围尚未明确。我们旨在研究单侧临床淋巴结阴性(cN0)PTC 患者对侧中央淋巴结转移(CCLNM)的发生率和危险因素,以确定适当的 pCLND 范围。

方法

使用 PubMed 和 Embase 数据库进行系统文献检索,直到 2018 年 5 月。纳入了估计临床病理因素与 CCLNM 之间关联的已发表研究。

结果

共有 6 项研究纳入了 1399 名患者。所有患者中 CCLNM 的发生率为 10.9%。汇总分析显示,男性(汇总 OR=1.67,95%CI=1.11-2.53,p=0.015)、年龄<45 岁(汇总 OR=1.97,95%CI=1.37-2.85,p<0.001)、血管侵犯(汇总 OR=4.23,95%CI=2.25-7.98,p<0.001)、甲状腺外侵犯(汇总 OR=1.75,95%CI=1.08-2.83,p=0.023)和同侧 CLNM(汇总 OR=12.26,95%CI=7.27-20.67,p<0.001)是 CCLNM 的显著危险因素。而肿瘤直径>1cm(汇总 OR=3.39,95%CI=0.83-13.88,P=0.090)、包膜侵犯(汇总 OR=1.28,95%CI=0.79-2.06,p=0.313)、甲状腺外延伸(汇总 OR=1.49,95%CI=0.86-2.56,p=0.152)和 MACIS≥6(汇总 OR=1.08,95%CI=0.51-2.26,p=0.844)与 CCLNM 无显著相关性。

结论

我们的荟萃分析确定男性、年龄<45 岁、血管侵犯、甲状腺外侵犯和同侧 CLNM 是 CCLNM 的显著危险因素。这些发现可能指导单侧 cN0 PTC 患者 pCLND 的范围。

相似文献

1
Risk factors for contralateral central lymph node metastasis in unilateral cN0 papillary thyroid carcinoma: A meta-analysis.单侧 cN0 期甲状腺乳头状癌对侧中央区淋巴结转移的危险因素:一项荟萃分析。
Int J Surg. 2018 Nov;59:90-98. doi: 10.1016/j.ijsu.2018.09.004. Epub 2018 Oct 17.
2
Risk Factors for Central Lymph Node Metastasis in CN0 Papillary Thyroid Carcinoma: A Systematic Review and Meta-Analysis.CN0 期乳头状甲状腺癌中央淋巴结转移的危险因素:一项系统评价与 Meta 分析
PLoS One. 2015 Oct 2;10(10):e0139021. doi: 10.1371/journal.pone.0139021. eCollection 2015.
3
Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma.预测甲状腺乳头状癌中央区淋巴结和侧颈区淋巴结转移的因素。
Clin Transl Oncol. 2019 Nov;21(11):1482-1491. doi: 10.1007/s12094-019-02076-0. Epub 2019 Mar 16.
4
The incidence and risk factors for central lymph node metastasis in cN0 papillary thyroid microcarcinoma: a meta-analysis.cN0 期甲状腺微小乳头状癌中央区淋巴结转移的发生率及危险因素:一项荟萃分析
Eur Arch Otorhinolaryngol. 2017 Mar;274(3):1327-1338. doi: 10.1007/s00405-016-4302-0. Epub 2016 Sep 19.
5
Predictive value of the Delphian lymph node in cervical lymph node metastasis of papillary thyroid carcinoma.Delphian 淋巴结对甲状腺乳头状癌颈淋巴结转移的预测价值。
Eur J Surg Oncol. 2021 Jul;47(7):1727-1733. doi: 10.1016/j.ejso.2021.02.010. Epub 2021 Feb 18.
6
Predictive factors for central lymph node metastasis in patients with cN0 papillary thyroid carcinoma: A systematic review and meta-analysis.cN0 期乳头状甲状腺癌患者中央淋巴结转移的预测因素:一项系统评价和荟萃分析
Int J Surg. 2016 Apr;28:153-61. doi: 10.1016/j.ijsu.2016.02.093. Epub 2016 Mar 2.
7
Clinical risk factors for central lymph node metastasis in papillary thyroid carcinoma: a systematic review and meta-analysis.甲状腺乳头状癌中央淋巴结转移的临床危险因素:一项系统评价和Meta分析
Clin Endocrinol (Oxf). 2015 Jul;83(1):124-32. doi: 10.1111/cen.12583. Epub 2014 Sep 22.
8
Pretracheal Lymph Node Subdivision in Predicting Contralateral Central Lymph Node Metastasis for Unilateral Papillary Thyroid Carcinoma: Preliminary Results.甲状腺癌术前气管前淋巴结分区与预测单侧甲状腺乳头状癌中央区淋巴结转移的关系:初步研究结果
Front Endocrinol (Lausanne). 2022 Jul 18;13:921845. doi: 10.3389/fendo.2022.921845. eCollection 2022.
9
High-risk factors for lymph node metastasis in contralateral central compartment in unilateral papillary thyroid carcinoma(cT1N0).单侧乳头状甲状腺癌(cT1N0)对侧中央区淋巴结转移的高危因素。
Eur J Surg Oncol. 2021 Apr;47(4):882-887. doi: 10.1016/j.ejso.2020.10.018. Epub 2020 Oct 18.
10
Meta-analysis of risk factors for CCLNM in patients with unilateral cN0 PTC.单侧cN0甲状腺乳头状癌患者中央区淋巴结转移风险因素的Meta分析
Endocr Connect. 2020 May 11;9(5):387-395. doi: 10.1530/EC-20-0058.

引用本文的文献

1
Propensity-matched comparison of microwave ablation and surgical resection for preoperative T1N0M0 papillary thyroid carcinoma: 5-year follow-up.术前T1N0M0乳头状甲状腺癌微波消融与手术切除的倾向评分匹配比较:5年随访
Eur Radiol. 2025 Aug 6. doi: 10.1007/s00330-025-11873-x.
2
Association between Thyroid Profile Levels and Lymph Node Metastasis in Papillary Thyroid Carcinoma: A Retrospective Study.甲状腺乳头状癌患者甲状腺功能指标水平与淋巴结转移的相关性:一项回顾性研究
Reports (MDPI). 2024 Sep 16;7(3):78. doi: 10.3390/reports7030078.
3
Multifactorial risk stratification for central lymph node metastasis in papillary thyroid carcinoma: a predictive model integrating clinical and tumor characteristics.
甲状腺乳头状癌中央淋巴结转移的多因素风险分层:整合临床和肿瘤特征的预测模型
Front Oncol. 2025 May 21;15:1586307. doi: 10.3389/fonc.2025.1586307. eCollection 2025.
4
Positive preoperative circulating tumor cells level associated with lymph node metastasis in papillary thyroid carcinoma patients with capsular invasion.术前循环肿瘤细胞水平呈阳性与有包膜侵犯的乳头状甲状腺癌患者的淋巴结转移相关。
World J Surg Oncol. 2025 May 14;23(1):190. doi: 10.1186/s12957-025-03842-x.
5
Preoperative circulating tumor cells level is associated with lymph node metastasis in patients with unifocal papillary thyroid carcinoma.术前循环肿瘤细胞水平与单灶性乳头状甲状腺癌患者的淋巴结转移相关。
World J Surg Oncol. 2025 Feb 11;23(1):47. doi: 10.1186/s12957-025-03702-8.
6
A radiopathomics model for predicting large-number cervical lymph node metastasis in clinical N0 papillary thyroid carcinoma.一种用于预测临床N0期乳头状甲状腺癌大量颈部淋巴结转移的放射组学模型。
Eur Radiol. 2025 Jan 29. doi: 10.1007/s00330-025-11377-8.
7
Interpretable machine learning models for predicting skip metastasis in cN0 papillary thyroid cancer based on clinicopathological and elastography radiomics features.基于临床病理和弹性成像放射组学特征的可解释机器学习模型用于预测cN0乳头状甲状腺癌的跳跃转移
Front Oncol. 2025 Jan 7;14:1457660. doi: 10.3389/fonc.2024.1457660. eCollection 2024.
8
Construction and validation of nomograms to predict central lymph node metastasis in clinical node-negative unilateral papillary thyroid carcinoma.预测临床N0期单侧甲状腺乳头状癌中央区淋巴结转移列线图的构建与验证
Sci Rep. 2025 Jan 21;15(1):2662. doi: 10.1038/s41598-025-86201-w.
9
Treatment outcomes in patients with papillary thyroid cancer undergoing radiofrequency ablation of metastatic lymph nodes.接受转移性淋巴结射频消融治疗的甲状腺乳头状癌患者的治疗结果
Gland Surg. 2024 Oct 31;13(10):1752-1758. doi: 10.21037/gs-24-285. Epub 2024 Oct 26.
10
Preoperative High Level of Circulating Tumor Cells is an Independent Risk Factor for Central Lymph Node Metastasis in Papillary Thyroid Carcinoma with Maximum Lesion Diameter ≤1.0 cm.术前循环肿瘤细胞高水平是最大病灶直径≤1.0 cm的乳头状甲状腺癌中央淋巴结转移的独立危险因素。
Int J Gen Med. 2024 Oct 25;17:4907-4916. doi: 10.2147/IJGM.S487992. eCollection 2024.